These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 8083675
1. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials. Bystritsky A, Waikar SV. J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675 [Abstract] [Full Text] [Related]
2. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R. Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643 [Abstract] [Full Text] [Related]
6. The antiobsessional effects of clomipramine do not require concomitant affective disorder. Katz RJ, DeVeaugh-Geiss J. Psychiatry Res; 1990 Feb; 31(2):121-9. PubMed ID: 2183254 [Abstract] [Full Text] [Related]
7. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M. Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562 [Abstract] [Full Text] [Related]
8. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Ananth J, Pecknold JC, van den Steen N, Engelsmann F. Prog Neuropsychopharmacol; 1981 Jun; 5(3):257-62. PubMed ID: 7022517 [No Abstract] [Full Text] [Related]
9. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Thorén P, Asberg M, Cronholm B, Jörnestedt L, Träskman L. Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690 [Abstract] [Full Text] [Related]
13. Fluvoxamine treatment of obsessive-compulsive disorder. Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R. Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604 [Abstract] [Full Text] [Related]
14. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J. Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637 [Abstract] [Full Text] [Related]
15. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. Pigott TA, L'Heureux F, Rubenstein CS, Bernstein SE, Hill JL, Murphy DL. J Clin Psychopharmacol; 1992 Jun; 12(3):156-62. PubMed ID: 1629380 [Abstract] [Full Text] [Related]
16. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD. Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576 [Abstract] [Full Text] [Related]
18. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL. Arch Gen Psychiatry; 1993 Jun; 50(6):441-7. PubMed ID: 8498878 [Abstract] [Full Text] [Related]
19. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913 [Abstract] [Full Text] [Related]